-
DAMGO (SKU B6621): Reliable µ-Opioid Receptor Agonist for Pa
2026-07-27
This article addresses common experimental challenges in opioid receptor signaling and pain modeling, providing scenario-driven guidance for using DAMGO (SKU B6621) as a selective µ-opioid receptor agonist. Drawing on peer-reviewed data and precise workflow advice, it demonstrates how DAMGO enables reproducible and sensitive results for chronic pain research and pharmacological studies.
-
2-Thio-dCTP: Precision DNA Modification for Molecular Biolog
2026-07-27
2-Thio-dCTP is a sulfur-modified nucleotide analog enabling site-specific DNA modification and DNA-protein interaction studies. Its unique structure allows precise interrogation of DNA polymerase specificity and facilitates advanced biochemical assays. APExBIO supplies 2-Thio-dCTP (SKU B8104) for research use, supporting workflows demanding high-fidelity nucleotide incorporation.
-
Necrostatin 2: Optimizing Necroptosis Inhibition Workflows
2026-07-26
Necrostatin 2 (Nec-2) offers precise, nanomolar inhibition of necroptosis via selective targeting of RIPK2, empowering reproducible cell death assays and translational disease models. This guide delivers advanced, evidence-based protocols, troubleshooting strategies, and key insights drawn from recent lipid scrambling and membrane remodeling research.
-
CX-4945 (Silmitasertib): CK2 Inhibition as a Precision Tool
2026-07-25
Explore how CX-4945 (Silmitasertib) advances CK2 inhibition strategies in cancer and host-pathogen studies, with new insights into viral interactions and research applications. This article offers a uniquely practical, evidence-based guide for advanced assay design.
-
BRCA2 Prevents PARP1 Retention to Safeguard RAD51 Filaments
2026-07-24
This study uncovers a direct mechanistic role of BRCA2 in mitigating PARP inhibitor-mediated PARP1 retention at DNA damage sites, thereby preserving RAD51 filament stability during homologous recombination repair. The findings clarify why BRCA2-deficient cells are especially sensitive to PARP inhibition and refine our understanding of PARP inhibitor selectivity in DNA repair-deficient cancer therapy.
-
Primidone (Mysoline): Inhibition Profiles and Research Proto
2026-07-24
Primidone (Mysoline) is a clinically established antiepileptic and anti-essential tremor drug with well-characterized inhibitory effects on TRPM3 channels, RIPK1 kinase, and human paraoxonase-1. Its noncompetitive inhibition of hPON1 is quantitatively defined, and dosing is protocolized for both cellular and animal models. APExBIO provides validated Primidone for translational research in epilepsy and beyond.
-
NSC-23766: Rac GTPase Inhibitor for Cancer Research Workflow
2026-07-23
NSC23766 trihydrochloride, as a selective Rac1 signaling pathway inhibitor, empowers researchers to dissect and manipulate Rac-driven processes in cancer, immune, and endothelial models. With workflow-friendly solubility and robust selectivity, it streamlines apoptosis induction and cell cycle studies while minimizing off-target effects.
-
Proximity Labeling Reveals New Pef1 Functions in Yeast Autop
2026-07-23
This study pioneers the use of APEX2-biotin phenol proximity labeling in Schizosaccharomyces pombe to map the interaction network of Pef1, a Cdk5 ortholog. The findings identify novel Pef1 interactors involved in lifespan regulation, autophagy, and DNA damage response, providing new insights into kinase-regulated cellular processes.
-
WAY-100635: Precision Antagonism for 5-HT1A Research Workflo
2026-07-22
WAY-100635 empowers neuroscience researchers to dissect serotonin 5-HT1A receptor function with exceptional selectivity and reproducibility. This guide translates recent mechanistic advances into actionable protocols and troubleshooting strategies for behavioral, imaging, and molecular assays.
-
FAISL lncRNA Shields FAK from Calpain 2, Driving TNBC Metast
2026-07-22
This study uncovers how the long noncoding RNA FAISL stabilizes focal adhesion kinase (FAK) by inhibiting its proteolysis via Calpain 2, thereby promoting progression and metastasis in triple negative breast cancer (TNBC). The results highlight FAISL as a key regulator of FAK signaling and a potential therapeutic target for aggressive breast cancers.
-
S63845 MCL1 Inhibitor: Precision Tool for Mitochondrial Apop
2026-07-21
S63845 is redefining apoptosis research by offering targeted, high-affinity inhibition of MCL1, enabling researchers to dissect BAX/BAK-dependent mitochondrial apoptotic pathways with unprecedented specificity. Recent insights into the interplay between apoptosis and ferroptosis, as well as robust in vitro and in vivo performance, position S63845 as an indispensable asset for hematological cancer studies and advanced mechanistic workflows.
-
Applied Workflows for Nicotinamide Adenine Dinucleotide (NAD
2026-07-21
Nicotinamide Adenine Dinucleotide (NAD+) is a pivotal coenzyme enabling precision mapping of metabolic signaling, cytoprotective autophagy, and DNA damage response. This article translates the latest bench research into actionable workflows, troubleshooting guidance, and advanced applications—empowering researchers to leverage APExBIO’s high-purity NAD+ in next-generation stress adaptation assays.
-
HyperScribe SP6 High Yield RNA Synthesis Kit: Applied Workfl
2026-07-20
The HyperScribe SP6 High Yield RNA Synthesis Kit empowers researchers with rapid, high-yield in vitro transcription for applications ranging from capped RNA synthesis to immune pathway interrogation. Discover protocol optimizations, troubleshooting tips, and the latest insights bridging RNA synthesis and innate immunity research.
-
(-)-JQ1 Stereoisomer: Gold-Standard Control for BET Assays
2026-07-20
(-)-JQ1, the inactive JQ1 stereoisomer, is essential for maximizing experimental specificity in BET bromodomain research. See how expert-driven workflows leverage this gold-standard control for rigorous validation in epigenetics and cancer biology studies.
-
Y-27632 Dihydrochloride: ROCK Inhibition for Neurodegenerati
2026-07-19
Explore how Y-27632 dihydrochloride, a potent ROCK inhibitor, advances neurodegeneration research by enabling precise modulation of endo-lysosomal dynamics and cell viability. This article delivers unique insights into assay design for Alzheimer’s disease models and bridges foundational Rho/ROCK biology to translational neuroscience.